SCI时时刷

search
+
Management and treatment of severe immune-related hepatotoxicity based on clinical and pathological characteristics
Management and treatment of severe immune-related hepatotoxicity based on clinical and pathological characteristics
The management of severe immune-related hepatotoxicity (irH) needs to be further optimized. This study aims to analyze the...
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
In 2020, a revised definition of fatty liver disease associated with metabolic dysfunction (MAFLD) was proposed to replace...
Treating extrahepatic portal-vein obstruction with cavernoma using radiological interventions: pushing the boundaries
Treating extrahepatic portal-vein obstruction with cavernoma using radiological interventions: pushing the boundaries
Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with an...
Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma
Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma
There is limited information on combination of hepatic arterial infusion chemotherapy (HAIC) and systemic therapy for adva...
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma
The aims of this study were to identify clinically significant biomarkers of a response to atezolizumab plus bevacizumab (...
Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis
Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis
The risk of hepatocellular carcinoma (HCC) occurrence following antiviral therapy in patients with chronic hepatitis C (CH...
Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis
Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis
The detection of autoantibodies is essential to diagnose autoimmune hepatitis (AIH). Particularly in children, specificity...
Chinese guidelines on the management of ascites in cirrhosis
Chinese guidelines on the management of ascites in cirrhosis
In 2023, Chinese Society of Hepatology of Chinese Medical Association convened a panel of experts to update the Chinese gu...
Impact of CT-relevant skeletal muscle parameters on post-liver transplantation survival in patients with hepatocellular carcinoma
Impact of CT-relevant skeletal muscle parameters on post-liver transplantation survival in patients with hepatocellular carcinoma
The specific CT-related skeletal muscle parameters predictive of postoperative survival in liver transplant (LT) patients ...
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group
Advances in surgical procedures and immunosuppressive therapies have considerably improved the outcomes of patients who ha...
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
Hepatocellular carcinoma (HCC) is undergoing a transformative shift, with metabolic-associated fatty liver disease (MAFLD)...
Dose–response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B
Dose–response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B
Evaluation of liver fibrosis played a monumental role in the diagnosis and monitoring of chronic hepatitis B (CHB). We aim...
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation
Previous studies have investigated the influence of diabetes on alcoholic liver cirrhosis patients, leaving its impact unc...
MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD
MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD
Metabolic dysfunction-associated fatty liver disease (MAFLD) is the liver manifestation of a metabolic syndrome and is hig...
Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis
Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis
The efficacy of achieving HBsAg clearance through pegylated interferon (PEG-IFNα) therapy in patients with chronic he...
Age-related differences in drug-induced liver injury: a retrospective single-center study from a large liver disease specialty hospital in China, 2002–2022
Age-related differences in drug-induced liver injury: a retrospective single-center study from a large liver disease specialty hospital in China, 2002–2022
Drug-induced liver injury (DILI) is a prevalent adverse reaction in clinical settings. However, there is limited research ...
Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome
Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome
Hepatocellular carcinoma (HCC) often develops from chronic liver inflammation. Inflammation within a tumor can either prom...
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptation
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptation
Healthy weight (lean) patients with metabolic dysfunction-associated fatty liver disease (MAFLD) have a more favorable met...
MAFLD: from a disease framework to patient care
MAFLD: from a disease framework to patient care
The year 2020 marked a watershed for Hepatology with an international panel suggestin...
Sleep patterns, genetic susceptibility, and risk of cirrhosis among individuals with nonalcoholic fatty liver disease
Sleep patterns, genetic susceptibility, and risk of cirrhosis among individuals with nonalcoholic fatty liver disease
The associations between sleep patterns or behaviors and the risk of cirrhosis and the influence of genetic susceptibility...
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
The historical use of the term non-alcoholic fatty liver disease (NAFLD) in obese/overweight children has been controversi...
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication o...
Review of current and new drugs for the treatment of metabolic-associated fatty liver disease
Review of current and new drugs for the treatment of metabolic-associated fatty liver disease
In the past 3 decades, metabolic-associated fatty liver disease (MAFLD) has emerged as a widespread liver condition, with ...
HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B
HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B
The role of neutrophils in hepatitis B virus (HBV) infection has been a subject of debate due to their involvement in anti...
Hepatic-associated vascular morphological assessment to predict overt hepatic encephalopathy before TIPS: a multicenter study
Hepatic-associated vascular morphological assessment to predict overt hepatic encephalopathy before TIPS: a multicenter study
To provide patients the chance of accepting curative transjugular intrahepatic portosystemic shunt (TIPS) rather than pall...
CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway
CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway
Chromobox Homolog 1 (CBX1) plays a crucial role in the pathogenesis of numerous diseases, including the evolution and adva...
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular–cholangiocarcinoma
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular–cholangiocarcinoma
Combined hepatocellular–cholangiocarcinoma (cHCC–CCA), as a rare primary hepatic tumor, is challenging to accu...
Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography
Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography
The Baveno VII consensus proposed criteria for the non-invasively diagnosis of clinically significant portal hypertension ...
Efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma: a propensity score-matched retrospective cohort study
Efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma: a propensity score-matched retrospective cohort study
Evidence concerning long-term outcome of robotic liver resection (RLR) and laparoscopic liver resection (LLR) for hepatoce...
Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial
Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial
Propranolol, a non-selective beta-blocker, commonly used to prevent variceal bleed, but might precipitate circulatory dysf...
阅读更多
format_indent_increase